Table 2.
Response | n | (%) | |
---|---|---|---|
AML (n=37) | CR/CRc | 2 | 5% |
CRi | 2 | 5% | |
mLFS | 7 | 19% | |
TF | 26 | 70% | |
MDS (n=14) | CR/CRc | 2 | 5% |
CRi | 0 | 0% | |
mCR | 4 | 11% | |
SD | 2 | 5% | |
Failure | 6 | 16% | |
HI-P, HI-N | 1 | 3% |
CR: Complete Remission; CRc: Cytogenetic CR; CRi: CR with incomplete blood count recovery; TF: Treatment failure; mLFS: Morphologic leukemia-free state; mCR: marrow CR; SD: stable disease; HI-P: Hematologic improvement-platelets; HI-N: Hematologic improvement-neutrophils